Saluda Medical Inc (ASX: SLD) — Perfil da empresa, notícias e dados financeiros
Saluda Medical Inc is a global medical device company specializing in the development and commercialization of closed-loop neuromodulation technologies for the treatment of chronic pain.
Saluda Medical Inc
Saluda Medical Inc is a global medical device company specializing in the development and commercialization of closed-loop neuromodulation technologies for the treatment of chronic pain. Founded on extensive physiological research, the company developed bio-sensing technology that measures evoked compound action potentials to record real-time spinal cord responses to neurostimulation. Its flagship closed-loop spinal cord stimulation platform continuously adjusts electrical dosage on a pulse-by-pulse basis to maintain consistent therapeutic levels. The company conducts clinical trials, collaborates with interventional pain specialists, and supplies implantable neurostimulation systems, patient care resources, and clinical software across international medical markets including the United States and Australia.
Resumo
Operações
Produtos e/ou serviços de Saluda Medical Inc
- Closed-Loop Spinal Cord Stimulation Systems: Commercialization of implantable pulse generator devices that measure real-time spinal cord physiological responses to deliver automated closed-loop electrical neurostimulation, designed to manage chronic trunk and limb pain across healthcare markets.
- Evoked Compound Action Potential Sensing Technology: Development of bio-sensing hardware and digital signal processing algorithms that continuously record evoked compound action potentials, enabling precise real-time measurement and physiological dosage adjustment for neuromodulation therapies.
- Clinical Evidence and Trial Programs: Execution of prospective randomized controlled clinical trials, long-term safety evaluations, and multi-center clinical registries to generate peer-reviewed data supporting closed-loop neurostimulation efficacy across multi-year follow-up periods.
- Physician Training and Clinical Support: Provision of clinical support, surgical onboarding programs, and technical resources for interventional pain specialists, neurosurgeons, and healthcare professionals deploying closed-loop spinal cord stimulation technologies in clinical settings.
- Reimbursement and Market Access Services: Delivery of health economics tools, coding guidance, and practice management resources to assist medical centers and clinical practices in securing insurance coverage and reimbursement for neuromodulation procedures.
- Patient Ambassador and Educational Resources: Management of direct-to-patient support initiatives, trial evaluation resources, and ambassador connection programs aimed at assisting candidates and chronic pain patients throughout their neuromodulation treatment continuum.
equipe executiva do Saluda Medical Inc
- Michael MathiasPresident, CEO & Director
- James EricksonChief Financial Officer
- Aidan O'SullivanChief Operations Officer
- Dean KarantonisChief Technology Officer
- Kristin S. CapliceChief Legal Officer & Secretary
- David FirstChief People Officer
Comunicados recentes
O que a Saluda Medical Inc (SLD) comunicou ao mercado, do mais recente para o mais antigo.
- Expands Access with Full US Commercial Release of CAP24
Principais indicadores financeiros
Resultados divulgados pela Saluda Medical Inc.
- Cap. de mercado
- 62,4 mi
- Receita (TTM)
- 90,2 mi
- P/L
- —
- LPA (diluído, TTM)
- -0.9
- Dividend yield
- —
- Margem de lucro
- -165.9%